Stocks › Biotechnology › DBVT

DBV Technologies DBVT

US equityMarket cap rank #3606Biotechnology

$9.77 −$0.21 (-2.10%)

Pre-market · Oct 8, 9:00 am ET · After hours $9.32 -4.61%

Open$9.74

Prev close$9.98

Day range$9.64 – $10.05

Volume535.3K

Market cap$614.03M

P/E (TTM)–

Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership105.9%+21.64 pts vs. prior quarter

Institutions holding101-1 vs. prior quarter

Insider trades (recent)22 buys / 13 sellsNet buying

Short interest2.15% of floatDays to cover 3.3 · as of 15 Sep 2026

Short-sale volume share23.0%5-day average of daily volume

Short-sale volume as % of daily volume

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$2.08M (4 inflow days, 16 outflow days).

Net flow by order size, last 20 sessions

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 52.9% of shares outstanding.

Largest holders

JPMorgan Chase & Co.13.39%
RA Capital Management, L.P.12.36%
MPM BioImpact LLC11.34%
Baker Bros. Advisors LP7.93%
Montanova Capital, LLC7.92%
Artal Group S.A.6.53%
Artisan Partners Limited Partnership6.28%
Janus Henderson Group plc5.22%

By investor type

VC/PE Fund41.62%
Hedge Fund27.91%
Public Company17.44%
Mutual Fund17.14%
Family Office/Trust0.81%
Private Company0.80%
Government Pension Fund0.20%
Individual/Insider0.04%

Reported short interest has held roughly steady near 2.15% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

Holder	Type	Period	Share change	New stake
BlackRock	Mutual Fund	2026/Q3	+48,556	0.7%
State Street Global Advisors	Mutual Fund	2026/Q3	+20,536	0.1%
JPMorgan Chase & Co.	Public Company	2026/Q3	+3,602,577	13.4%
MPM BioImpact LLC	VC/PE Fund	2026/Q3	+3,044,658	11.3%
RA Capital Management, L.P.	VC/PE Fund	2026/Q3	+7,315,288	12.4%
Logos Global Management, L.P.	Hedge Fund	2026/Q3	+915,000	1.5%
Morgan Stanley	Public Company	2026/Q3	+808,792	1.6%
Perceptive Advisors LLC	VC/PE Fund	2026/Q3	+688,959	2.8%
Patient Square Capital, LP	VC/PE Fund	2026/Q3	+215,940	1.5%
Jane Street Group, LLC	Private Company	2026/Q3	+212,630	0.4%
Great Point Partners, LLC	VC/PE Fund	2026/Q3	+156,906	0.3%
Columbia Management Investment Advisers, LLC	Mutual Fund	2026/Q3	+147,080	0.6%
Hudson River Trading LLC	Private Company	2026/Q3	+127,112	0.3%
Ishara Investments, L.P.	Hedge Fund	2026/Q3	+82,000	0.3%
Deutsche Asset & Wealth Management	Mutual Fund	2026/Q3	+59,240	0.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

Date	Insider	Title	Transaction	Shares	Price	Held after
28 Jul 2026	Pharis Mohideen	Chief Medical Officer	Private Disposition	-464	$2.70	53,344
28 Jan 2026	Pharis Mohideen	Chief Medical Officer	Private Disposition	-534	$4.86	50,370
11 Jan 2026	Julian Baker		Other Derivative Acquisition	+27,304,896	–	25,005,240
17 Dec 2025	Bpifrance Participations SA		Private Disposition	-3,369,093	$5.28	7,529,502
20 Nov 2025	Daniel Tassé	Chief Executive Officer	Other Derivative Acquisition	+964,000	$2.90	964,000
20 Nov 2025	Virginie Simone Jeanine Boucinha	Chief Financial Officer	Other Acquisition	+32,000	–	55,750
20 Nov 2025	Virginie Simone Jeanine Boucinha	Chief Financial Officer	Other Derivative Acquisition	+192,000	$2.90	192,000
20 Nov 2025	Pharis Mohideen	Chief Medical Officer	Other Acquisition	+44,000	–	95,713
20 Nov 2025	Pharis Mohideen	Chief Medical Officer	Other Derivative Acquisition	+253,000	$2.90	253,000
20 Nov 2025	Kevin Trapp	Former Chief Commercial Officer	Other Acquisition	+55,000	–	55,000
20 Nov 2025	Kevin Trapp	Former Chief Commercial Officer	Other Derivative Acquisition	+316,250	$2.90	316,250
20 Nov 2025	Pharis Mohideen	Chief Medical Officer	Private Disposition	-8,120	$2.88	49,817
28 Jul 2025	Pharis Mohideen	Chief Medical Officer	Private Disposition	-464	$2.22	38,249
21 May 2025	Pharis Mohideen	Chief Medical Officer	Private Disposition	-397	$1.84	37,463
26 Mar 2025	Julian Baker		Other Derivative Acquisition	+27,304,896	–	25,005,240
26 Mar 2025	Bpifrance Participations SA		Initial Statement of Beneficial	+0	–	6,556,781
26 Mar 2025	EPIC Bpifrance, Asset Management Arm		Initial Statement of Beneficial	+0	–	–
29 Jan 2025	Pharis Mohideen	Chief Medical Officer	Private Disposition	-600	$0.85	34,585
3 Dec 2024	Daniel Tassé	Chief Executive Officer	Other Derivative Acquisition	+813,200	$0.89	813,200
24 Nov 2024	Pharis Mohideen	Chief Medical Officer	Private Disposition	-565	$0.57	33,935

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report date	Shares short	% of float	Days to cover
15 Sep 2026	1,353,244	2.2%	3.3
31 Aug 2026	1,583,924	2.5%	9.7
14 Aug 2026	1,633,383	2.6%	4.0
31 Jul 2026	1,848,774	3.1%	5.0
15 Jul 2026	1,470,719	2.5%	7.8
30 Jun 2026	1,299,136	2.2%	3.7

Discussion

No comments yet — be the first to weigh in on DBVT.